Videos and Media

The Elliot Lewis Center participated in WALK MS to benefit the National MS Society on Sunday, April 3rd. Thank you to our patients, friends and families who joined us to support the National MS Society at Walk MS Boston. Team ELC had over 60 team members and raised over $7,500!

The Elliot Lewis Center is participating in WALK MS Boston to benefit the National MS Society on Sunday, April 3rd. The Elliot Lewis Center is inviting patients, families, friends and caregivers to participate in Walk MS! The event that brings together a community of passionate people to connect and raise funds to change the world…

Evusheld is now available at The Elliot Lewis Center. Evusheld provides antibodies against COVID for people with an incomplete response to the vaccines. Find out more about Evusheld, who is eligible, and how to get it in the video below.

Two new studies came out showing the Epstein-Barr virus (EBV) may be “the cause” of MS. Q&A with Dr. Katz.

This is a very interesting study. We always knew Epstein-Barr virus was an important risk factor for MS. Now it appears it may actually directly cause MS! What does this mean? Perhaps this could lead to more targeted treatments and prevention! Read the full article in the January 2022 issue of Science, here.

Q&A with Dr. Katz. On New Year’s Eve 2021, Dr. Katz conducted a virtual Q&A session on the topic of COVID-19 to discuss recommendations for monoclonal antibody treatments, boosters, and what might be coming in the next few weeks and months.

Confused about insurance? Health insurance and financial assistance can be complicated. Marissa Shackleton spoke with the Siegel Rare Neuroimmune Association on Friday to explain insurance and access to care. Marissa answers questions such as: What are insurance benefits? Who is eligible for medicare and medicaid? What is open enrollment? How can I get assistance to…

We’re pleased to announce that our paper, “Humoral and T-Cell Responses to SARS-CoV-2 Vaccination in Multiple Sclerosis Patients Treated with Ocrelizumab” was published today! We’re extremely proud and grateful to all of you who participated! Your contributions added to our scientific knowledge and understanding! Read the full article here.

The ELC research team presented at the annual The Consortium of Multiple Sclerosis Centers this week. ELC treated the first patient with commercial Ocrevus nationwide in 2017 and has been collecting data on Ocrevus patients in “ACAPELLA” ever since. The team presents data on ACAPELLA at CMSC and ECTRIMS annually. NeurologyLive highlighted ACAPELLA: Real-World Experience…

Thank you NICA – National Infusion Center Association for spotlighting our center and infusion suite! Our infusion suite is conveniently located within the multiple sclerosis center for streamlined care. Our physicians are on-site, our infusion nurses are multiple sclerosis certified and our infusion coordinator is an expert at navigating insurance and financial assistance!